{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:13:42Z","timestamp":1789578822715,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Objective<\/jats:title>\n The aim of this study was to characterize large adrenal tumors (LATs), assess the diagnostic accuracy of imaging modalities in detecting malignant LATs, and determine whether further follow-up of seemingly benign LATs is necessary.<\/jats:p>\n <\/jats:sec>\n \n Patients and methods<\/jats:title>\n We retrospectively analyzed the clinical, biochemical, and imaging characteristics at presentation and during follow-up in a single-center cohort of patients with adrenal tumors \u22654 cm in diameter evaluated between June 2013 and June 2023.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 1,473 patients with adrenal tumors, 269 (18.3%) had lesions measuring \u22654 cm in diameter, of whom 220 were included in the study. Among LATs, 34.6% were adrenocortical adenomas, 27.3% other benign adrenal tumors, 17.3% adrenocortical carcinomas, 11.4% other malignant tumors, and 9.6% pheochromocytomas. Overall, 44.7% of tumors were non-functioning, while 37.8% secreted corticosteroids. Sensitivity of unenhanced computed tomography attenuation values in detecting malignancy was 100% using the threshold &gt;10 Hounsfield units (HU) and 89.5% for &gt;20 HU (with specificity 66.1% and 81.4%, respectively). Magnetic resonance with chemical shift analysis demonstrated high sensitivity (94.4%) but low specificity (56.8%).\n 18<\/jats:sup>\n F-fluorodeoxyglucose-positron emission tomography integrated with computed tomography showed 100% sensitivity using an adrenal liver ratio &gt; 1. When the maximum standardized uptake value &gt;5 cutoff was applied, sensitivity remained 100%, while specificity improved (100% vs. 82.1%). Eighty-seven tumors were managed with follow-up, with a mean duration of 30.1 months. Significant tumor growth occurred in four cases (4.6%): three myelolipomas and one indeterminate lesion in a patient with extra-adrenal malignancy. Adrenalectomy was performed in six patients (6.9%). Although these tumors were initially classified as adrenocortical adenomas, histopathology revealed benign lesions in five cases and adrenocortical carcinoma in one. The risk of developing mild autonomous cortisol secretion among non-functioning tumors was 6.7%. No progression to overt Cushing\u2019s syndrome was observed.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Although the risk of malignancy increases with tumor size, most LATs are benign. Imaging modalities demonstrate high sensitivity for detecting malignancy in LATs. No malignancies were identified in homogeneous lesions with attenuation &lt;10 HU. LATs that do not meet these benign imaging criteria should undergo multidisciplinary evaluation and continued follow-up.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1774131","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:54:43Z","timestamp":1771397683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Natural history of large adrenal tumors"],"prefix":"10.3389","volume":"17","author":[{"given":"Magdalena","family":"Macech","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Podg\u00f3rska","sequence":"additional","affiliation":[{"name":"Second Department of Clinical Radiology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Toutounchi","sequence":"additional","affiliation":[{"name":"Department of General, Vascular, Endocrine and Transplant Surgery, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Koperski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Barankiewicz","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Bobrowicz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kondracka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Ambroziak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Endocrinology, Medical University of Warsaw","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known Malignancy","volume":"190","author":"Song","year":"2008","journal-title":"Am J Roentgenol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12957-019-1765-7","article-title":"Clinical analysis of adrenal lesions larger than 5 cm in diameter (an analysis of 251 cases)","volume":"17","author":"Zhang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2017.11.002","article-title":"Clinical, biochemical, and radiological characteristics of a single-center retrospective cohort of 705 large adrenal tumors","volume":"2","author":"I\u00f1iguez-Ariza","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.2.6372","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000185477","article-title":"Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group","volume":"47","author":"Angeli","year":"1997","journal-title":"Horm Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1627","article-title":"Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas\/hyperplasias from nonadenomas: Cleveland clinic experience","volume":"90","author":"Hamrahian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: Imaging for the diagnosis of Malignancy in incidentally discovered adrenal masses: A systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1148\/radiology.217.3.r00dc29798","article-title":"Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT","volume":"217","author":"Pena","year":"2000","journal-title":"Radiology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.179.3.1790559","article-title":"Imaging of adrenal incidentalomas: Current status","volume":"179","author":"Dunnick","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-011-0089-z","article-title":"Conventional imaging in adrenocortical carcinoma: update and perspectives","volume":"2","author":"Young","year":"2011","journal-title":"Horm Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0650","article-title":"Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from Malignant adrenal masses","volume":"186","author":"Schloetelburg","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13448","article-title":"Diagnostic performance of unenhanced computed tomography and 18F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4158\/EP.15.5.450","article-title":"American association of clinical endocrinologists; american association of endocrine surgeons. American association of clinical endocrinologists and american association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"French Society of Endocrinology Consensus. Exploration and management of adrenal incidentalomas","volume":"69","author":"Tabarin","year":"2008","journal-title":"French Soc Endocrinol Consensus. Ann Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1147","article-title":"Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2017.32.2.200","article-title":"Korean Endocrine Society, Committee for Clinical Practice Guidelines. Clinical guidelines for the management of adrenal incidentaloma","volume":"32","author":"Lee","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2016.0039","article-title":"Adrenal incidentaloma in adults - management recommendations by the Polish Society of Endocrinology","volume":"67","author":"Bednarczuk","year":"2016","journal-title":"Endokrynol Pol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000631","article-title":"Approach to large adrenal tumors","volume":"28","author":"Ambroziak","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: An endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2017.0039","article-title":"Adrenal tumour bigger than 5 cm - What could it be? An analysis of 139 cases","volume":"68","author":"Cichocki","year":"2017","journal-title":"Endokrynol Pol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1619","article-title":"Prevalence and characteristics of adrenal tumors in an unselected screening population : A cross-sectional study","volume":"175","author":"Jing","year":"2022","journal-title":"Preval Charact Adrenal Tumors an Unselected Screen Popul A Cross-Sectional Study"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","author":"Eisenhofer","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5626-5","article-title":"Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis","volume":"29","author":"Platzek","year":"2019","journal-title":"Eur Radiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"20170520","DOI":"10.1259\/bjr.20170520","article-title":"Diagnostic accuracy of 18F-FDG PET or PET\/CT for the characterization of adrenal masses: A systematic review and meta-analysis","volume":"91","author":"Kim","year":"2018","journal-title":"Br J Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess A systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00178-9","article-title":"Adrenal myelolipomas","volume":"9","author":"Calissendorff","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming Malignant; time for a rethink","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1774131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:54:44Z","timestamp":1771397684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1774131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":37,"alternative-id":["10.3389\/fendo.2026.1774131"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1774131","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1774131"}}